# VitaDAO

> VitaDAO is a VC fund in New York backing Biotechnology and Genetics. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 2
- Last investment: Jul 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/vitadao/about/
- X (Twitter): https://twitter.com/vita_dao
- Website: https://www.vitadao.com/

VitaDAO is a decentralized collective funding early stage longevity research Our mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.VitaDAO and its members are committed to nurturing and developing the intellectual property, licenses, and data sets that resultfrom the projects it supports.Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or Intellectual Property.

## Contacts

5 contacts available for VitaDAO. Shizune tracks 6 team members at VitaDAO. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/vitadao?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Genetics | 1 | 50% |
| InsurTech | 1 | 50% |
| Health Care | 1 | 50% |
| Pharmaceutical | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alex Dobrin | Awareness Steward | 0 | https://shizune.co/investors/profile/alex-dobrin |
| Laurence Ion | Dealflow Steward | 0 | https://shizune.co/investors/profile/laurence-ion |
| Matthew ‘Oki’ O’Connor | Senior Reviewer | 0 | https://shizune.co/investors/profile/matthew-oki-o-connor-131c |
| Paul Kohlhaas | Founding Steward | 0 | https://shizune.co/investors/profile/paul-kohlhaas |
| Sebastian Brunemeier | Longevity Working Group | 3 | https://shizune.co/investors/profile/sebastian-aguiar |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ImmuneAGE Bio | ImmuneAGE Bio is an intriguing initiative focused on drug discovery for immune system rejuvenation. Developing therapies that can rejuvenate or enhance the immune system could have profound implications for healthcare, especially in aging populations or those with compromised immune function | $2M | Seed | Jul 11, 2024 |  |
| Gero | GERO is an AI Drug Discovery company created to solve chronic diseases. To date, Gero has raised approximately $19 million in total capital through a combination of equity rounds and SAFEs. | $6M | Series A | Oct 18, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [1517 Fund](https://shizune.co/investors/profile/1517-fund) — VC Fund, 1 deal together
- [Emerging Longevity Ventures](https://shizune.co/investors/profile/emerging-longevity-ventures) — VC Fund, 1 deal together
- [Healthspan Capital](https://shizune.co/investors/profile/healthspan-capital) — VC Fund, 1 deal together
- [Infinita Fund](https://shizune.co/investors/profile/infinita-fund) — VC Fund, 1 deal together
- [Melnichek Investments](https://shizune.co/investors/profile/melnichek-investments) — VC Fund, 1 deal together
- [Pareto Holdings](https://shizune.co/investors/profile/pareto-holdings) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Singapore](https://shizune.co/investors/biotechnology-investors-singapore)
- [InsurTech Investors in Singapore](https://shizune.co/investors/insurtech-investors-singapore)
- [InsurTech VC Funds in Singapore](https://shizune.co/investors/insurtech-vc-funds-singapore)

## FAQ

### What does VitaDAO invest in?

VitaDAO invests primarily in Biotechnology, Genetics and InsurTech startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact VitaDAO?

Public channels for VitaDAO include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at VitaDAO?

The team at VitaDAO includes Alex Dobrin (Awareness Steward), Laurence Ion (Dealflow Steward) and Matthew ‘Oki’ O’Connor (Senior Reviewer), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co